dc.contributor.author | ALTINTOPRAK, Niyazi | |
dc.contributor.author | Demir, Mehmet Gökhan | |
dc.contributor.author | Aydin, Sedat | |
dc.contributor.author | Kosemihal, Ebru | |
dc.contributor.author | BILMEZ, Zekiye Eda Bekmez | |
dc.contributor.author | SANLI, Arif | |
dc.contributor.author | ERDOGAN, Banu Atalay | |
dc.date.accessioned | 2021-03-06T09:17:22Z | |
dc.date.available | 2021-03-06T09:17:22Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | BILMEZ Z. E. B. , Aydin S., SANLI A., ALTINTOPRAK N., Demir M. G. , ERDOGAN B. A. , Kosemihal E., "Oxytocin as a protective agent in cisplatin-induced ototoxicity", CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.77, ss.875-879, 2016 | |
dc.identifier.issn | 0344-5704 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_e4e260fe-dfec-4b5e-8d1c-136df1521752 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/150604 | |
dc.identifier.uri | https://doi.org/10.1007/s00280-016-2978-x | |
dc.description.abstract | Cisplatin is a potent chemotherapeutic drug with serious side effects such as ototoxicity which is characterized by irreversible, bilateral, progressive sensorineural hearing loss. Oxytocin, which is a well-known hormone secreting during pregnancy, has antioxidant and antiinflammatory effect. Our study aims to test and compare the effect of intratympanic (IT) and intraperitoneal (IP) oxytocin on cisplatin ototoxicity with DPOAE. | |
dc.language.iso | eng | |
dc.subject | İç Hastalıkları | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Onkoloji | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.title | Oxytocin as a protective agent in cisplatin-induced ototoxicity | |
dc.type | Makale | |
dc.relation.journal | CANCER CHEMOTHERAPY AND PHARMACOLOGY | |
dc.contributor.department | Bahcelievler State Hospital , , | |
dc.identifier.volume | 77 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 875 | |
dc.identifier.endpage | 879 | |
dc.contributor.firstauthorID | 105812 | |